Vulvovaginal candida infections and boric acid treatments (AJP February 2019)

Accredited CPD
Group 2 

Provider: AJP 
Author: Rebecca O'Grady

CPD Credits: 1.5

Overview 

Designed to give an overview of the treatment of vulvovaginal candida infections caused by Candida glabrata.

Learning Objectives

After completing this activity, pharmacists should be able to:

1. list the different pathogens that commonly cause vulvovaginal candidiasis;
2. list the treatment options for vulvovaginal candidiasis;
3. describe methods used in the preparation of compounded boric acid treatments

The 2016 Competency Standards addressed by this activity include: 1.4, 1.5, 2.1, 2.2, 2.3, 3.1, 3.3, 3.4

Accreditation number: A1902AJP2     Accreditation expires: 01/02/2021
This activity has been accredited for 0.75 hour of Group One CPD (or 0.75 CPD credit) suitable for inclusion in an individual pharmacist’s CPD plan, which may be converted to 0.75 hour of Group Two CPD (or 1.5 CPD credits) upon successful completion of the associated assessment activity.